Adeoye Y. Olukotun, Director at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 16,910 shares at $66.70 ($1.1M) on 2025-12-19, disclosed to the SEC on 2025-12-23.
Scheduled sale ($1.1M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.70 | 3,090 | $206K | 18.0% |
| 2 | $68.04 | 6,083 | $414K | 36.1% |
| 3 | $68.04 | 6,083 | $414K | 36.1% |
| 4 | $68.48 | 827 | $57K | 4.9% |
| 5 | $68.48 | 827 | $57K | 4.9% |
| Total | $67.84 avg | 16,910 |
| $1.1M |
| 100% |
| Filing → |
| ARWR | SELL | 2024-12-30 | $57K | — | Filing → |
| ARWR | SELL | 2023-03-06 | $741K | — | Filing → |
| ARWR | SELL | 2022-01-04 | $508K | — | Filing → |